Delivery Order SPE2DB22D1017-SPE2DB25FG2VV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Multaq 400 mg tablets (60-count) valued at $9,625.47 under a firm fixed-price contract. This non-set-aside award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units, valued at $2,947.88. This competitive award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, utilizes firm fixed pricing under a non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units, valued at $4,506.52. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13.8K delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Multaq 400 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a competitively awarded, non-set-aside contract with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,549.80 on July 29, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 30, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $1,871.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Multaq 400 mg tablets (60-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $6,030.23 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count units). This firm fixed-price contract, which is a child order under a larger vehicle, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order draws...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,959.09. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a non-competitive procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Multaq 400 mg tablets (60-count packaging) with a ceiling value of $7,225.78. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $1,866.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, with an ultimate completion date of July 24, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. This award involved no set-aside designation,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG2VVDelivery Order
The Defense Logistics Agency awarded a $1,232.98 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units. The contract, which is not set-aside, has an ultimate completion date of May 19, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger indefinite delivery vehicle that enables the company to support the military's pharmaceutical supply chain. This award falls under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor with extensive federal contracting experience, AmerisourceBergen supplies a broad range of medications and medical commodities to support military and veteran healthcare operations globally. Multaq is a cardiac antiarrhythmic medication commonly used in military healthcare settings, and this delivery order fulfills an immediate pharmaceutical requirement within the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/16/25 |